Mass General Hospital Gets Funding to Sequence Rare Melanoma Subtypes, Hunt for Novel Drug Targets
The research is focused on mucosal and acral melanomas, tumors that don't have the molecular features that allow cutaneous melanoma patients to respond to targeted drugs.
United States Nir Hacohen Genevieve Boland Genentech Zelboraf Melanoma Research Alliance Nature Communications
Source: precisiononcologynews.com